New HINJ Report: Economic Impact of HINJ Members Reaches All-Time High
More than $22 billion total economic impact on state 69,209 directly employed by industry Average base salary is $80,246 Capital investment of nearly $2.4 billion Charitable contributions totaled $45.5 Hillside, NJ, April 15, 2003 — Despite the sluggish economy, member companies of the HealthCare Institute of New Jersey (HINJ) contributed more than $22 billion to […]
Growing Numbers of Uninsured Underscores the Need for a Medicare Prescription Drug Benefit, Says HINJ
Hillside, NJ, March 25, 2003 — The HealthCare Institute of New Jersey (HINJ) today called on Congress to enact a Medicare Prescription Drug Benefit, which would give seniors and the disabled full access to innovative medicines that will help them live longer, healthier and more productive lives.
Statement Regarding the New Jersey Life Sciences Super-Cluster Initiative
By The Honorable Bob Franks, President, HealthCare Institute of New Jersey Hillside, NJ, February 14, 2003 — HealthCare Institute of New Jersey (HINJ) President Bob Franks today issued the following statement:
HINJ Reports More Than a Third of FDA-Approved Drugs Came from New Jersey in 2002
New Brunswick, NJ, February 10, 2003 — New Jersey-based pharmaceutical companies developed more than a third of all the new medicines approved by the U.S. Food and Drug Administration (FDA) in 2002, according to statistics compiled by the HealthCare Institute of New Jersey (HINJ). Of the 17 new drugs, 7 came from the Garden State.
What a Member of Congress Needs to Know from the Life Sciences Industry
By The Honorable Bob Franks, President, HealthCare Institute of New Jersey New Brunswick, NJ, February 1, 2003 — As the new President of the HealthCare Institute of New Jersey (HINJ), I have a simple, yet compelling belief: Our collective voice can have a profound impact on New Jersey’s policy makers.
The New Congress: What It Means for HINJ Members and the Life Sciences Industry
New Brunswick, NJ, February 1, 2003 — During the new 108th Congress, seniors may finally get a Medicare Prescription Drug Benefit. A Prescription Drug Benefit for all Medicare beneficiaries is just one of the issues likely to be taken up in Washington this year.
Heldrich Report: The Pharmaceutical/Medical Technology Industry Will Add Almost 15,000 New Jobs
State Needs To Produce More Skilled Graduates Trenton, NJ, November 12, 2002 — New Jersey’s pharmaceutical and medical technology companies are growing and will add almost 15,000 new jobs by the end of this decade, according to a recent report issued by the John J. Heldrich Center for Workforce Development at Rutgers, the State University […]
Government Price Controls on Prescription Drugs May Be More than Patients Bargain For
New Brunswick, NJ, October 7, 2002 — Many critics of the pharmaceutical industry contend that the fastest and easiest way to lower prescription drug costs is for the government to impose price controls. That chorus is gaining momentum in state houses around the nation, as well as in Congress.
Discover Why We Are New Jersey’s ‘Premier’ Industry
New Brunswick, NJ, October 7, 2002 — For years, the telecommunications industry dominated our state’s economy. But over the last decade, the pharmaceutical and medical technology industry has become the key driver of our state’s economic well-being. This is evidenced by the fact that New Jersey is home to more pharmaceutical and medical technology companies […]
Continuing Our Progress Depends on Today’s Health Care Policy Decisions
New Brunswick, NJ, October 7, 2002 — The proliferation of prescription drugs and medical devices has dramatically changed health care over the past quarter century. It also has dramatically changed the HealthCare Institute of New Jersey’s member companies.